{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T13:44:42Z","timestamp":1762177482073,"version":"3.41.2"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T00:00:00Z","timestamp":1650844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p>Marfan syndrome (MFS) is an autosomal dominant connective tissue disorder that canonically affects the ocular, skeletal, and cardiovascular system, in which aortic tear and rupture is the leading cause of death for MFS patients. Genetically, MFS is primarily associated with fibrillin-1 (FBN1) pathogenic variants. However, the disease-causing variant in approximately 10% of patients cannot be identified, partly due to some cryptic mutations that may be missed using routine exonic sequencing, such as non-coding intronic variants that affects the RNA splicing process. We present a 32-year female with typical MFS systemic presentation that reached to a clinical diagnosis according to the revised Ghent nosology. We performed whole-exome sequencing (WES) but the report failed to identify known causal variants when analyzing the exonic sequence. However, further investigation on the exon\/intron boundaries of the WES report revealed a candidate intronic variant of the fibrillin 1 (FBN1) gene (c.248-3 C&amp;gt;G) that predicted to affect the RNA splicing process. We conducted minigene splicing analyses and demonstrated that the c.248-3 C&amp;gt;G variant abolished the canonical splicing site of intron 3, leading to activation of two cryptic splicing sites and causing insertion (c.248-1_248-2insAG and c.248-1_248-282ins). Our study not only characterizes an intronic variant to the mutational spectrum of the FBN1 gene in MFS and its aberrant effect on splicing, but highlights the importance to not neglect the exon\/intron boundaries when reporting and assessing WES results. We point out the need of conducting functional analysis to verify the pathogenicity of intronic mutation, and the opportunity to re-consider the standard diagnostic approaches in cases of clinically diagnosed MFS with normal or variant of unknown significance genetic results.<\/jats:p>","DOI":"10.3389\/fgene.2022.857095","type":"journal-article","created":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T07:25:33Z","timestamp":1650871533000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Functional Analysis of an Intronic FBN1 Pathogenic Gene Variant in a Family With Marfan Syndrome"],"prefix":"10.3389","volume":"13","author":[{"given":"Kui","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-Tsuen","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinmiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haonan","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenwei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lufang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojuan","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liqun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daokang","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/s41436-020-01078-6","article-title":"Unsuspected Somatic Mosaicism for FBN1 Gene Contributes to Marfan Syndrome","volume":"23","author":"Arnaud","year":"2021","journal-title":"Genet. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmolb.2021.749842","article-title":"Classification and Interpretation for 11 FBN1 Variants Responsible for Marfan Syndrome and Pre-Implantation Genetic Testing (PGT) for Two Families Successfully Blocked Transmission of the Pathogenic Mutations","volume":"8","author":"Chen","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.mayocp.2013.08.022","article-title":"Epidemiological Profile of Marfan Syndrome in a General Population: A National Database Study","volume":"89","author":"Chiu","year":"2014","journal-title":"Mayo Clinic Proc."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1093\/eurheartj\/ehu281","article-title":"2014 ESC Guidelines on the Diagnosis and Treatment of Aortic Diseases","volume":"35","author":"Erbel","year":"2014","journal-title":"Eur. Heart J."},{"key":"B5","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/ejhg.2008.207","article-title":"Clinical and Mutation-Type Analysis from an International Series of 198 Probands with a Pathogenic FBN1 Exons 24-32 Mutation","volume":"17","author":"Faivre","year":"2009","journal-title":"Eur. J. Hum. Genet."},{"key":"B6","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1086\/520125","article-title":"Effect of Mutation Type and Location on Clinical Outcome in 1,013 Probands with Marfan Syndrome or Related Phenotypes and FBN1 Mutations: An International Study","volume":"81","author":"Faivre","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/humu.22540","article-title":"An FBN1 Deep Intronic Mutation in a Familial Case of Marfan Syndrome: An Explanation for Genetically Unsolved Cases?","volume":"35","author":"Gillis","year":"2014","journal-title":"Hum. Mutat."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-015-0369-8","article-title":"Prevalence, Incidence, and Age at Diagnosis in Marfan Syndrome","volume":"10","author":"Groth","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s10038-008-0334-7","article-title":"An FBN1 Pseudoexon Mutation in a Patient with Marfan Syndrome: Confirmation of Cryptic Mutations Leading to Disease","volume":"53","author":"Guo","year":"2008","journal-title":"J. Hum. Genet."},{"key":"B10","doi-asserted-by":"crossref","DOI":"10.1007\/978-94-007-7893-1","volume-title":"Progress in Heritable Soft Connective Tissue Diseases","author":"Halper","year":"2014"},{"key":"B11","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/ejhg.2010.174","article-title":"The Clinical Spectrum of Complete FBN1 Allele Deletions","volume":"19","author":"Hilhorst-Hofstee","year":"2011","journal-title":"Eur. J. Hum. Genet."},{"key":"B12","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1161\/CIR.0b013e3181d4739e","article-title":"2010 ACCF\/AHA\/AATS\/ACR\/ASA\/SCA\/SCAI\/SIR\/STS\/SVM Guidelines for the Diagnosis and Management of Patients with Thoracic Aortic Disease","volume":"121","author":"Hiratzka","year":"2010","journal-title":"Circulation"},{"key":"B13","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1001\/jamacardio.2019.1176","article-title":"Update on Clinical Trials of Losartan with and without \u03b2-Blockers to Block Aneurysm Growth in Patients with Marfan Syndrome","volume":"4","author":"Hofmann Bowman","year":"2019","journal-title":"JAMA Cardiol."},{"key":"B14","first-page":"1335","article-title":"Progression of Aortic Dilatation and the Benefit of Long-Term \u03b2-Adrenergic Blockade in Marfan's Syndrome","volume-title":"N. Engl. J. Med.","author":"Jennifer","year":"1994"},{"key":"B15","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/jmg.2009.072785","article-title":"The Revised Ghent Nosology for the Marfan Syndrome","volume":"47","author":"Loeys","year":"2010","journal-title":"J. Med. Genet."},{"key":"B16","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/352334a0","article-title":"Marfan Syndrome Caused by a Recurrent","volume":"352","author":"Maslen","year":"1991","journal-title":"Nature"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-021-00298-7","article-title":"Marfan Syndrome","volume":"7","author":"Milewicz","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"B18","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1161\/CIRCRESAHA.118.312436","article-title":"Genetics of Thoracic and Abdominal Aortic Diseases","volume":"124","author":"Pinard","year":"2019","journal-title":"Circ. Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1038\/s41436-018-0399-4","article-title":"Marfan Syndrome: Improved Clinical History Results in Expanded Natural History","volume":"21","author":"Pyeritz","year":"2019","journal-title":"Genet. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.tcm.2015.12.003","article-title":"Recent Progress in Understanding the Natural and Clinical Histories of the Marfan Syndrome","volume":"26","author":"Pyeritz","year":"2016","journal-title":"Trends Cardiovasc. Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/aos.13972_502","article-title":"Standards and Guidelines for the Interpretation of Sequence Variants","volume":"96","author":"Richards","year":"2018","journal-title":"Acta Ophthalmol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1136\/jmg.2005.039669","article-title":"The Molecular Genetics of Marfan Syndrome and Related Disorders","volume":"43","author":"Robinson","year":"2006","journal-title":"J. Med. Genet."},{"key":"B23","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1086\/341581","article-title":"Premature Termination Mutations in FBN1: Distinct Effects on Differential Allelic Expression and on Protein and Clinical Phenotypes","volume":"71","author":"Schrijver","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/3536495","article-title":"A Novel Heterozygous Intronic Mutation in the FBN1 Gene Contributes to FBN1 RNA Missplicing Events in the Marfan Syndrome","volume":"2018","author":"Torrado","year":"2018","journal-title":"Biomed. Res. Int."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1002\/mgg3.489","article-title":"Survival, Causes of Death, and Cardiovascular Events in Patients with Marfan Syndrome","volume":"6","author":"Vanem","year":"2018","journal-title":"Mol. Genet. Genomic Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/echo.14577","article-title":"Prenatal Diagnosis of Marfan Syndrome by Fetal Echocardiography: A Case Report and Review of Cardiovascular Manifestations","volume":"37","author":"Wang","year":"2020","journal-title":"Echocardiography"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41065-020-00170-w","article-title":"A Novel Intron Mutation in FBN-1 Gene Identified in a Pregnant Woman with Marfan Syndrome","volume":"158","author":"Wu","year":"2021","journal-title":"Hereditas"},{"key":"B28","doi-asserted-by":"publisher","first-page":"9028","DOI":"10.1111\/jcmm.16866","article-title":"Identification of Compound Heterozygous DNAH11 Variants in a Han\u2010Chinese Family with Primary Ciliary Dyskinesia","volume":"25","author":"Xiong","year":"2021","journal-title":"J. Cel. Mol. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40246-018-0178-y","article-title":"Identification of Gross Deletions in FBN1 Gene by MLPA","volume":"12","author":"Yang","year":"2018","journal-title":"Hum. Genomics"},{"key":"B30","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/978-3-030-80614-9_8","article-title":"Pathophysiology and Pathogenesis of Marfan Syndrome","volume":"1348","author":"Zeigler","year":"2021","journal-title":"Adv. Exp. Med. Biol."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2022.857095\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T07:25:38Z","timestamp":1650871538000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2022.857095\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,25]]},"references-count":30,"alternative-id":["10.3389\/fgene.2022.857095"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2022.857095","relation":{},"ISSN":["1664-8021"],"issn-type":[{"type":"electronic","value":"1664-8021"}],"subject":[],"published":{"date-parts":[[2022,4,25]]},"article-number":"857095"}}